A number of big-ticket deals in high-growth sectors such as telecommunications and renewables signal a bright future for French dealmaking

Leveraged finance activity in the healthcare sector made strong gains through Q1 2021 as the pandemic response saw the industry attract steady investor inflows and M&A interest

The Act's Key Achievements

Soaring demand in high-growth industries is causing a steady flow of PE investment into the sector

New challenges may lie ahead for the pharmaceutical industry

SMRs are gaining the attention of governments and power providers across the world because of the optionality they offer. But the champions of the SMR will have to work hard to ensure its potential can be fully unlocked.

The number of distressed and liquidation-related M&A deals, especially in the US and UK, has increased year on year as businesses struggle to adapt to their post-pandemic reality.

Tightening liability spreads and the backlog from 2020 have seen European collateralized loan obligations resetting and refinancing at historic levels in 2021

Management fee credit facilities have become increasingly popular among private equity firms during the pandemic as a tool to manage cash flow volatility

Emerging technologies attract increasing interest from dealmakers, buoyed by strong economic fundamentals and healthy macroeconomics

There have been a number of developments in merger control in 2020 and Q1 2021. Some are related to the repercussions of the COVID-19 pandemic, while others are borne out of the ambitions and changes sought by individual competition authorities or unexpected jurisprudence